Glucotrack, Inc. Files 8-K
Ticker: GCTK · Form: 8-K · Filed: Jul 8, 2025 · CIK: 1506983
Sentiment: neutral
Topics: disclosure, financials
TL;DR
Glucotrack filed an 8-K on 7/8/25 for Reg FD disclosure and financials.
AI Summary
Glucotrack, Inc. filed an 8-K on July 8, 2025, to report a Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not contain specific financial figures or details about the nature of the disclosure.
Why It Matters
This 8-K filing indicates Glucotrack, Inc. is making a regulatory disclosure and providing financial statements, which could contain material information for investors.
Risk Assessment
Risk Level: low — The filing is a standard 8-K for disclosures and financial statements without immediate negative or positive financial implications mentioned.
Key Players & Entities
- Glucotrack, Inc. (company) — Registrant
- July 8, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of Incorporation
- 001-41141 (identifier) — Commission File Number
- 98-0668934 (identifier) — IRS Employer Identification No.
- 301 Rte. 17 North, Ste. 800, Rutherford, NJ 07070 (address) — Principal executive offices
FAQ
What specific information is being disclosed under Regulation FD?
The filing does not specify the content of the Regulation FD disclosure.
What financial statements are included in this filing?
The filing indicates that financial statements are included, but their specific content or period is not detailed in the provided text.
When was Glucotrack, Inc. incorporated?
Glucotrack, Inc. was incorporated in Delaware.
What is the principal executive office address for Glucotrack, Inc.?
The principal executive offices are located at 301 Rte. 17 North, Ste. 800, Rutherford, NJ 07070.
What is the Commission File Number for Glucotrack, Inc.?
The Commission File Number for Glucotrack, Inc. is 001-41141.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 8, 2025 regarding Glucotrack, Inc. (GCTK).